Comparison of amino acid compositions of peptides eluted from HLA-B27 molecules of healthy individuals and patients with ankylosing spondylitis.

[1]  A. McMichael,et al.  HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors1 , 2004, The Journal of Immunology.

[2]  J. Čapková,et al.  Peptides eluted from HLA-B27 of human splenocytes and blood cells reveal a similar but partially different profile compared to in vitro grown cell lines. , 2004, Immunology letters.

[3]  M. Vázquez,et al.  HLA-B27: a registry of constitutive peptide ligands. , 2004, Tissue antigens.

[4]  S. Bombardieri,et al.  Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. , 2004, The Journal of rheumatology.

[5]  J. Taurog,et al.  HLA-B27 in Transgenic Rats Forms Disulfide-Linked Heavy Chain Oligomers and Multimers That Bind to the Chaperone BiP1 , 2004, The Journal of Immunology.

[6]  E. Bergseng,et al.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Saenger,et al.  Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide , 2004, The Journal of experimental medicine.

[8]  M. Marcilla,et al.  Species-specific Differences in Proteasomal Processing and Tapasin-mediated Loading Influence Peptide Presentation by HLA-B27 in Murine Cells* , 2003, Journal of Biological Chemistry.

[9]  F. Koning.  The molecular basis of celiac disease , 2003, Journal of molecular recognition : JMR.

[10]  A. McMichael,et al.  Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. , 2002, Arthritis and rheumatism.

[11]  M. Ramos,et al.  HLA-B27 and the pathogenesis of spondyloarthritis. , 2002, Tissue antigens.

[12]  R. Colbert,et al.  HLA-B27 Misfolding Is Associated with Aberrant Intermolecular Disulfide Bond Formation (Dimerization) in the Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.

[13]  J. Drijfhout,et al.  Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease , 2002, The Journal of experimental medicine.

[14]  M. Ramos,et al.  Minimal alterations in the HLA-B27-bound peptide repertoire induced upon infection of lymphoid cells with Salmonella typhimurium. , 2001, Arthritis and rheumatism.

[15]  Todd M. Allen,et al.  Gorillas with Spondyloarthropathies Express an MHC Class I Molecule with Only Limited Sequence Similarity to HLA-B27 that Binds Peptides with Arginine at P21 , 2001, The Journal of Immunology.

[16]  J. Čapková,et al.  Strong association of HLA-B27 heavy chain with β2-microglobulin , 2000 .

[17]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[18]  J. Ringrose.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? , 1999, Annals of the rheumatic diseases.

[19]  M. Bonneville,et al.  Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27. , 1999, Journal of immunology.

[20]  L. Fugger,et al.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.

[21]  P. Iványi,et al.  Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. , 1998, Transplantation.

[22]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[23]  J. Albar,et al.  Lack of carboxil-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis , 1997 .

[24]  A. Marina,et al.  Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis. , 1997, Tissue antigens.

[25]  J. Shabanowitz,et al.  Susceptibility to ankylosing spondylitis correlates with the C‐terminal residue of peptides presented by various HLA‐B27 subtypes , 1997, European journal of immunology.

[26]  J. Shabanowitz,et al.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.

[27]  William Arbuthnot Sir Lane,et al.  A subset of HLA-B27 molecules contains peptides much longer than nonamers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Harley,et al.  A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Fleischer,et al.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis , 1993, The Lancet.

[30]  P. Iványi.  Immunogenetics of the spondyloarthropathies. , 1993, Current Opinion in Rheumatology.

[31]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[32]  V. Havlíček,et al.  Mass spectrometric analysis of the glycosphingolipid‐enriched microdomains of rat natural killer cells , 2005, Proteomics.

[33]  A. Suzuki,et al.  Citrullinated proteins in rheumatoid arthritis. , 2005, Frontiers in bioscience : a journal and virtual library.

[34]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[35]  D. Rognan,et al.  An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. , 1998, Tissue antigens.

[36]  A. Toubert,et al.  HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes , 1997, Immunogenetics.

[37]  H. Rammensee,et al.  Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.

[38]  D. Urry,et al.  Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. , 1991, Critical reviews in biochemistry and molecular biology.

[39]  P. Parham,et al.  Guilt by association: HLA-B27 and ankylosing spondylitis. , 1990, Immunology today.